{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:17:19Z","timestamp":1780665439148,"version":"3.54.1"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Programa para el Desarrollo Profesional Docente","award":["CA-160 FACMED"],"award-info":[{"award-number":["CA-160 FACMED"]}]},{"DOI":"10.13039\/501100015029","name":"Vicerrector\u00eda de Investigaci\u00f3n y Estudios de Posgrado, Benem\u00e9rita Universidad Aut\u00f3noma de Puebla","doi-asserted-by":"publisher","award":["GOMM-SAL22-G"],"award-info":[{"award-number":["GOMM-SAL22-G"]}],"id":[{"id":"10.13039\/501100015029","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The aim was to evaluate the effect different types of abdominal fat have on NAFLD development and the effects of abdominal fat has on the association between Metabolic Syndrome (MetS) and NALFD.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Data was collected from the cross-sectional NHANES dataset (2017\u20132018 cycle). Using the controlled attenuation parameter (USG CAP, dB\/m), which measures the level of steatosis, the cohort was stratified into two groups: NAFLD(+) (\u2265274 dB\/m) and NAFLD(-). Using complex samples analyses, associations between liver steatosis or NAFLD and types of abdominal fat area [Total abdominal (TAFA), subcutaneous (SAT), and visceral (VAT)] were determined. Pearson\u2019s correlation coefficient (r) was calculated to evaluate the associations between adipose tissues and NAFLD. Logistic regression was used to determine the risk [odds ratio (OR) and 95% confidence interval (95%CI)]. Participants were also classified by MetS, using the Harmonizing Definition criteria.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Using 1,980 participants (96,282,896 weighted), there was a significant (p&lt;0.001) correlation between USG CAP and TAFA (r = 0.569), VAT (r = 0.645), and SAT (r = 0.479). Additionally, the risk of developing NAFLD was observed for total abdominal obesity (OR = 19.9, 95%CI: 5.1\u201377.8, p&lt;0.001), visceral obesity (OR = 9.1, 95%CI: 6.2\u201313.5, p&lt;0.001) and subcutaneous obesity (OR = 4.8, 95%CI: 3.2\u20136.9, p&lt;0.001). Using 866 participants (44,399,696 weighted), for visceral obesity, participants with MetS and visceral obesity (OR = 18.1, 95%CI: 8.0\u201341.3, p&lt;0.001) were shown to have a greater risk than participants with MetS only (OR = 6.3, 95%CI: 2.6\u201315.2, p&lt;0.001). For subcutaneous obesity, again, participants with MetS and subcutaneous obesity (OR = 18.3, 95%CI: 8.0\u201341.9, p&lt;0.001) were shown to have a greater risk than the MetS-only group (OR = 10.3, 95%CI: 4.8\u201322.4, p&lt;0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>TAFA, VAT, and SAT were positively associated with USG CAP values and increased the risk of developing NAFLD. Also, the type of abdominal fat depots did affect the association between MetS and NAFLD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0298662","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:32:17Z","timestamp":1708713137000},"page":"e0298662","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome\u2019s effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017\u20132018"],"prefix":"10.1371","volume":"19","author":[{"given":"Rebeca Garazi","family":"Elguezabal Rodelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo M.","family":"Porchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Torres\u2010Rasgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-7587","authenticated-orcid":true,"given":"Esther","family":"L\u00f3pez-Bayghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Elba","family":"Gonzalez-Mejia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"issue":"9","key":"pone.0298662.ref001","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"K Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"pone.0298662.ref002","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","article-title":"Ethnicity and nonalcoholic fatty liver disease","volume":"55","author":"K Bambha","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"pone.0298662.ref003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"pone.0298662.ref004","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/MEG.0000000000001235","article-title":"Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies","volume":"30","author":"D Tomic","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"pone.0298662.ref005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2016.07.003","article-title":"Nonalcoholic Fatty Liver Disease: Pathophysiology and Management","volume":"45","author":"RM Carr","year":"2016","journal-title":"Gastroenterol Clin North Am"},{"key":"pone.0298662.ref006","unstructured":"World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995; 854:1\u2013452. 8594834."},{"key":"pone.0298662.ref007","volume-title":"Obesity","author":"KK Panuganti","year":"2022"},{"issue":"6","key":"pone.0298662.ref008","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ","volume":"89","author":"EE Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0298662.ref009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease","volume":"7","author":"A Chait","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"pone.0298662.ref010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"MM Ibrahim","year":"2010","journal-title":"Obes Rev"},{"issue":"4","key":"pone.0298662.ref011","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.ATV.10.4.493","article-title":"\"Portal\" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes","volume":"10","author":"P. Bjorntorp","year":"1990","journal-title":"Arteriosclerosis"},{"key":"pone.0298662.ref012","first-page":"26","article-title":"Lipolysis in human adipocytes, effects of cell size, age and of regional differences","volume":"19","author":"P Engfeldt","year":"1988","journal-title":"Horm Metab Res Suppl"},{"issue":"8","key":"pone.0298662.ref013","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00125-007-0708-y","article-title":"Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis","volume":"50","author":"T McLaughlin","year":"2007","journal-title":"Diabetologia"},{"issue":"10","key":"pone.0298662.ref014","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1742-1241.2008.01848.x","article-title":"Is adiposopathy (sick fat) an endocrine disease?","volume":"62","author":"HE Bays","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"7121","key":"pone.0298662.ref015","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"JP Despres","year":"2006","journal-title":"Nature"},{"issue":"10","key":"pone.0298662.ref016","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3949\/ccjm.75.10.721","article-title":"Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome","volume":"75","author":"CH Kim","year":"2008","journal-title":"Cleve Clin J Med"},{"issue":"2","key":"pone.0298662.ref017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MCG.0000000000000666","article-title":"The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population","volume":"51","author":"R Jinjuvadia","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"pone.0298662.ref018","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clnesp.2019.04.010","article-title":"Visceral and subcutaneous adipose tissue association with metabolic syndrome and its components in a South African population","volume":"32","author":"TE Matsha","year":"2019","journal-title":"Clin Nutr ESPEN"},{"issue":"1","key":"pone.0298662.ref019","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1038\/s41598-017-09723-y","article-title":"Body Fat Distribution and the Risk of Incident Metabolic Syndrome: A Longitudinal Cohort Study","volume":"7","author":"H Kwon","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0298662.ref020","unstructured":"CDC. National Health and Nutrition Examination Survey 1999\u20132022 (NHANES): U.S. Department of Health & Human Services; 2022 [updated August 24, 2022; cited 2022 May 1]. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=2017."},{"key":"pone.0298662.ref021","unstructured":"CDC. NHANES NCHS Ethics Review Board Approval 1999\u20132022: U.S. Department of Health & Human Services; 2022 [updated August 24, 2022; cited 2022 May 1]. https:\/\/www.cdc.gov\/nchs\/nhanes\/irba98.htm."},{"key":"pone.0298662.ref022","unstructured":"CDC. NHANES Questionnaires, Datasets, and Related Documentation 1999\u20132022: U.S. Department of Health & Human Services; 2022 [updated August 24, 2022; cited 2022 May 1]. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/Default.aspx."},{"key":"pone.0298662.ref023","article-title":"Replication Data for: \"Visceral and subcutaneous abdominal fat is associated with Non-alcoholic fatty liver disease\"","author":"ME Gonzalez-Mejia","year":"2024","journal-title":"Harvard Dataverse"},{"key":"pone.0298662.ref024","unstructured":"CDC. NHANES Procedure Manuals 2017\u20132018: U.S. Department of Health & Human Services; 2022 [updated August 24, 2022; cited 2022 May 1]. https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/manuals.aspx?Cycle=2017-2018."},{"issue":"6","key":"pone.0298662.ref025","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"TM Wallace","year":"2004","journal-title":"Diabetes Care"},{"issue":"6","key":"pone.0298662.ref026","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3346\/jkms.2006.21.6.1048","article-title":"Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population","volume":"21","author":"JA Kim","year":"2006","journal-title":"J Korean Med Sci"},{"issue":"5","key":"pone.0298662.ref027","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1575-0922(07)71446-8","article-title":"Significado cl\u00ednico de la obesidad abdominal","volume":"54","author":"PL Velasco_De Pablos","year":"2007","journal-title":"Endocrinolog\u00eda y nutrici\u00f3n"},{"issue":"11","key":"pone.0298662.ref028","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"M Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"issue":"5","key":"pone.0298662.ref029","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"T Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0298662.ref030","doi-asserted-by":"crossref","first-page":"e24225","DOI":"10.1002\/jcla.24225","article-title":"The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults","volume":"36","author":"N Yang","year":"2022","journal-title":"J Clin Lab Anal"},{"issue":"16","key":"pone.0298662.ref031","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"KG Alberti","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"pone.0298662.ref032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"JA Hanley","year":"1982","journal-title":"Radiology"},{"issue":"2","key":"pone.0298662.ref033","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/0033-2909.87.2.245","article-title":"Tests for comparing elements of a correlation matrix","volume":"87","author":"JH Steiger","year":"1980","journal-title":"Psychological bulletin"},{"key":"pone.0298662.ref034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.metabol.2016.10.003","article-title":"Obesity is more closely related with hepatic steatosis and fibrosis measured by transient elastography than metabolic health status","volume":"66","author":"JH Huh","year":"2017","journal-title":"Metabolism"},{"issue":"48","key":"pone.0298662.ref035","first-page":"2379","article-title":"The value and limitations of the body mass index (BMI) in the assessment of the health risks of overweight and obesity","volume":"148","author":"P Kok","year":"2004","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"Suppl 3","key":"pone.0298662.ref036","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/ijo.2008.87","article-title":"BMI-related errors in the measurement of obesity","volume":"32","author":"KJ Rothman","year":"2008","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"pone.0298662.ref037","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/eurheartj\/ehp487","article-title":"Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality","volume":"31","author":"A Romero-Corral","year":"2010","journal-title":"Eur Heart J"},{"key":"pone.0298662.ref038","doi-asserted-by":"crossref","first-page":"592404","DOI":"10.5402\/2011\/592404","article-title":"Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease","volume":"2011","author":"MS Mirza","year":"2011","journal-title":"ISRN Gastroenterol"},{"issue":"6","key":"pone.0298662.ref039","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1440-1746.2007.05212.x","article-title":"Visceral adipose tissue area is an independent risk factor for hepatic steatosis","volume":"23","author":"BJ Park","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"pone.0298662.ref040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1440-1746.2008.05474.x","article-title":"VAT fat is bad for the liver, SAT fat is not!","volume":"23","author":"JG Fan","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"pone.0298662.ref041","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cld.1183","article-title":"Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue","volume":"19","author":"CL Hanlon","year":"2022","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"4","key":"pone.0298662.ref042","doi-asserted-by":"crossref","first-page":"416","DOI":"10.20945\/2359-3997000000055","article-title":"Waist circumference measurement sites and their association with visceral and subcutaneous fat and cardiometabolic abnormalities","volume":"62","author":"CPS Pinho","year":"2018","journal-title":"Arch Endocrinol Metab"},{"issue":"9","key":"pone.0298662.ref043","doi-asserted-by":"crossref","first-page":"E439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","author":"IJ Neeland","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"pone.0298662.ref044","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.metabol.2018.11.009","article-title":"Metabolically healthy versus metabolically unhealthy obesity","volume":"92","author":"C Iacobini","year":"2019","journal-title":"Metabolism"},{"issue":"2","key":"pone.0298662.ref045","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans","volume":"26","author":"N Stefan","year":"2017","journal-title":"Cell Metab"},{"issue":"3","key":"pone.0298662.ref046","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/livers3030033","article-title":"Relationship between Non-Alcoholic Fatty Liver Disease and Visceral Fat Measured by Imaging-Based Body Composition Analysis: A Systematic Review","volume":"3","author":"KM Seaw","year":"2023","journal-title":"Livers"},{"key":"pone.0298662.ref047","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"S Mitra","year":"2020","journal-title":"Translational gastroenterology and hepatology"},{"issue":"1","key":"pone.0298662.ref048","doi-asserted-by":"crossref","first-page":"10977","DOI":"10.1038\/s41598-022-14701-0","article-title":"Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study","volume":"12","author":"W Wang","year":"2022","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0298662.ref049","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hep4.1668","article-title":"Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD","volume":"5","author":"K Wegermann","year":"2021","journal-title":"Hepatol Commun"},{"issue":"1","key":"pone.0298662.ref050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13293-022-00475-7","article-title":"Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study","volume":"13","author":"S Fresneda","year":"2022","journal-title":"Biol Sex Differ"},{"issue":"2","key":"pone.0298662.ref051","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cgh.2017.09.041","article-title":"Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis","volume":"16","author":"NE Rich","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"pone.0298662.ref052","first-page":"71","article-title":"Diversity in NAFLD: A Review of Manifestations of Nonalcoholic Fatty Liver Disease in Different Ethnicities Globally","volume":"9","author":"MAT Han","year":"2021","journal-title":"J Clin Transl Hepatol"},{"issue":"9","key":"pone.0298662.ref053","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.crad.2010.03.013","article-title":"Distribution of abdominal adipose tissue as a predictor of hepatic steatosis assessed by MRI","volume":"65","author":"PH Ducluzeau","year":"2010","journal-title":"Clin Radiol"},{"issue":"1","key":"pone.0298662.ref054","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cgh.2015.07.024","article-title":"Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease","volume":"14","author":"D Kim","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"46","key":"pone.0298662.ref055","doi-asserted-by":"crossref","first-page":"e17879","DOI":"10.1097\/MD.0000000000017879","article-title":"Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study","volume":"98","author":"T Kure","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"pone.0298662.ref056","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4254\/wjh.v13.i7.763","article-title":"Racial differences in prevalence and severity of non-alcoholic fatty liver disease","volume":"13","author":"M Bonacini","year":"2021","journal-title":"World J Hepatol"},{"issue":"7","key":"pone.0298662.ref057","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"M Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"12","key":"pone.0298662.ref058","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"S Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"3","key":"pone.0298662.ref059","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"SG Sepanlou","year":"2020","journal-title":"The Lancet gastroenterology & hepatology"},{"issue":"6","key":"pone.0298662.ref060","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/hep.28677","article-title":"Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort","volume":"64","author":"VW Setiawan","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"pone.0298662.ref061","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000282101","article-title":"The effect of lifestyle changes in non-alcoholic fatty liver disease","volume":"28","author":"E Centis","year":"2010","journal-title":"Dig Dis"},{"issue":"6","key":"pone.0298662.ref062","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"X Ouyang","year":"2008","journal-title":"J Hepatol"},{"issue":"11","key":"pone.0298662.ref063","doi-asserted-by":"crossref","first-page":"9127","DOI":"10.3390\/nu7115454","article-title":"Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance","volume":"7","author":"H. Yki-Jarvinen","year":"2015","journal-title":"Nutrients"},{"key":"pone.0298662.ref064","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/DMSO.S198744","article-title":"Dietary patterns in relation to hepatic fibrosis among patients with nonalcoholic fatty liver disease","volume":"12","author":"D Soleimani","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"pone.0298662.ref065","first-page":"7","volume":"5","author":"L. Labban","year":"2018","journal-title":"The Association between Visceral Fat, Dietary Patterns, and Comorbidities"},{"issue":"4","key":"pone.0298662.ref066","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/nutrit\/nuu006","article-title":"Qualitative aspects of diet affecting visceral and subcutaneous abdominal adipose tissue: a systematic review of observational and controlled intervention studies","volume":"73","author":"K Fischer","year":"2015","journal-title":"Nutrition reviews"},{"issue":"4","key":"pone.0298662.ref067","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3349\/ymj.2016.57.4.885","article-title":"The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter","volume":"57","author":"YE Chon","year":"2016","journal-title":"Yonsei Med J"},{"key":"pone.0298662.ref068","doi-asserted-by":"crossref","first-page":"739875","DOI":"10.3389\/fendo.2021.739875","article-title":"Validation of Controlled Attenuation Parameter Measured by FibroScan as a Novel Surrogate Marker for the Evaluation of Metabolic Derangement","volume":"12","author":"Z Huang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0298662.ref069","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12664-019-00991-2","article-title":"Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease","volume":"39","author":"Shalimar","year":"2020","journal-title":"Indian J Gastroenterol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:32:59Z","timestamp":1708713179000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0298662"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0298662","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}